RenuTend; forsyningsvanskelighed
Safety Classified by Officially
Der er aktuelle problemer med forsyningen af RenuTend injektionsvæske, suspension fra Boehringer Ingelheim Animal Health Nordics A/S.
Produkt: RenuTend injektionsvæske, suspension
Aktivt stof: Chondrogenisk inducerede equine allogeneiske mesenkymale stamceller af periferal blod-oprindelse (hestestamceller)
Forventet periode: Slut august 2024 - slut april 2027
Virksomhed: Boehringer Ingelheim Animal Health Nordics A/S
This is an extract. The publication continues at the source.
Source: Lægemiddelstyrelsen.
Read the original at the source: https://laegemiddelstyrelsen.dk/da/godkendelse/kontrol-og-inspektion/mangel-paa-medicin/meddelelser-om-forsyning-af-medicin/veterinaer-2024/renutend-forsyningsvanskelighed/
Officially imported this from Lægemiddelstyrelsen’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Lægemiddelstyrelsen — imported from official source
- Official source
- https://laegemiddelstyrelsen.dk/da/Feeds/rss-feed/ RSS
- Imported
- October 20, 2026 12:33
- Versions
- 1 recorded
- Identity
-
12C757746A594D329C1D89ACA52AD522